Farah Succaria is a Dermatology physician affiliated with Johns Hopkins University. OpenAlex indexes 33 publications with 597 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Clinical Evaluation of a Multi-functional Beauty Device on Cosmetic Skin Outcomes
Sponsor: APR Co., Ltd.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20251 payment
- Janssen Biotech, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30.6%Azole Antifungal22.5%Ketoconazole100%Part D≥21 patientsLincosamide Antibacterial8.1%Clindamycin Phosphate100%Part D<11 patientsSensory organs
29.2%Corticosteroid29.2%Clobetasol Propionate34%Desonide34%Hydrocortisone31%Part D≥12 patientsDermatology
25.4%Corticosteroid15.8%Triamcinolone Acetonide100%Part D≥23 patientsInterleukin-4 Receptor alpha Antagonist9.6%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Burned by misinformation: Ethics of communication after dermatologic product recalls
Journal of the American Academy of Dermatology
2026 - When skin disease affects intimacy: The ethical duty for dermatologists to screen for sexual dysfunction
Clinics in Dermatology
2026 - When a social media post becomes a consult: Navigating online requests for dermatologic care
Journal of the American Academy of Dermatology
2026 - Letters without signatures: Who decides for our patients? Ethical limits of non-dermatologist prior authorization reviewers
Journal of the American Academy of Dermatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Clifton Bingham, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”